Product Detail

CRYPZAR 1.125 GM INJ

CRYPZAR 1.125 GM

Piperacillin 1g + Tazobactam 125mg Inj

Treats serious nosocomial infections.

Treats serious nosocomial infections. Applied in lower respiratory tract infections (pneumonia). Effective in urinary tract infections. Treats intra-abdominal infections. Applied in septicemia and skin infections.

MRP: ₹99.55/-

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Treats serious nosocomial infections. Applied in lower respiratory tract infections (pneumonia). Effective in urinary tract infections. Treats intra-abdominal infections. Applied in septicemia and skin infections.

Side Effects

  • Pain at injection site. Diarrhea, nausea. Rash, itching. Higher liver enzymes Rare: Anemia (low WBC/platelets).

Uses

Treats serious nosocomial infections. Applied in lower respiratory tract infections (pneumonia). Effective in urinary tract infections. Treats intra-abdominal infections. Applied in septicemia and skin infections.

Side Effects

  • Pain at injection site. Diarrhea, nausea. Rash, itching. Higher liver enzymes Rare: Anemia (low WBC/platelets).

Indications

  • Complex intra-abdominal infections. Lower respiratory tract infections. Septicemia. Urinary tract infections.

FAQ

Q1. Why is Tazobactam added?
It guards Piperacillin against bacterial resistance.

Q2. Is it safe in kidney patients?
Dose adjustment is required

Q3. Is it applicable in fever of unknown origin?
Yes, common in hospitals.

Q4. Is it administrable in ICU patients?
Yes, used in critically ill.

Q5. Is it broad-spectrum?
Yes, it is active against gram-positive and gram-negative bacteria.

Indications

  • Complex intra-abdominal infections. Lower respiratory tract infections. Septicemia. Urinary tract infections.

FAQ

Q1. Why is Tazobactam added?
It guards Piperacillin against bacterial resistance.

Q2. Is it safe in kidney patients?
Dose adjustment is required

Q3. Is it applicable in fever of unknown origin?
Yes, common in hospitals.

Q4. Is it administrable in ICU patients?
Yes, used in critically ill.

Q5. Is it broad-spectrum?
Yes, it is active against gram-positive and gram-negative bacteria.

Request a Callback